CELU.NASDAQCelularity INC

8-K: Celularity Inc. Announces Date for 2024 Annual Meeting and Sets Deadlines for Stockholder Proposals

Sentiment:

Corporate Governance Update


Celularity Inc. has set the date for its 2024 Annual Meeting of Stockholders for December 19, 2024, and established deadlines for stockholder proposals.

Summary

  • Celularity Inc. has scheduled its 2024 Annual Meeting of Stockholders for Thursday, December 19, 2024.
  • The record date for determining stockholders eligible to vote at the meeting was Friday, November 8, 2024.
  • Due to the meeting date being more than 30 days after the anniversary of the 2023 meeting, the company is providing notice of deadlines for stockholder proposals.
  • Stockholder proposals for inclusion in the proxy materials must be submitted by the close of business on November 18, 2024.
  • Proposals must comply with Celularity's bylaws and SEC regulations.
  • Any stockholder intending to submit a proposal or director nomination not for inclusion in the proxy materials must also submit notice by November 18, 2024.

Sentiment

Score: 7

Explanation: The document is a routine announcement of the annual meeting and deadlines, which is neutral to slightly positive as it indicates the company is following standard corporate governance procedures.

Positives

  • The company has clearly communicated the date of the annual meeting and deadlines for stockholder proposals.
  • The company is adhering to SEC regulations regarding the timing of the annual meeting and stockholder proposals.

Risks

  • Failure to meet the deadlines for submitting proposals may result in them not being considered at the annual meeting.
  • Stockholders may not be aware of the deadlines and may miss the opportunity to submit proposals.

Future Outlook

The company will proceed with the 2024 Annual Meeting of Stockholders on December 19, 2024, and will review any stockholder proposals submitted by the deadline.

Management Comments

  • Robert J. Hariri, M.D., Ph.D., Chairman and CEO, signed the report on behalf of Celularity Inc.

Industry Context

This announcement is a routine part of corporate governance for publicly traded companies, ensuring shareholders have the opportunity to participate in company decisions.

Comparison to Industry Standards

  • The process of setting a record date and deadlines for shareholder proposals is standard practice for publicly listed companies in the US.
  • The timing of the annual meeting and the deadlines for proposals are consistent with SEC regulations and best practices for corporate governance.
  • Many companies such as Amgen, Gilead, and Regeneron follow similar procedures for their annual meetings.

Stakeholder Impact

  • Shareholders are informed of the date of the annual meeting and deadlines for submitting proposals.
  • Shareholders have the opportunity to participate in the company's governance by submitting proposals and voting at the annual meeting.

Next Steps

  • Celularity will review and consider stockholder proposals submitted by the November 18, 2024 deadline.
  • The company will prepare proxy materials for the 2024 Annual Meeting.
  • The 2024 Annual Meeting of Stockholders will be held on December 19, 2024.

Key Dates

DateDescription
2023-06-14Date of the 2023 Annual Meeting of Stockholders.
2024-11-08Record date for the 2024 Annual Meeting of Stockholders.
2024-11-08Date of the report.
2024-11-18Deadline for submitting stockholder proposals for inclusion in proxy materials and for submitting notice of proposals not for inclusion.
2024-12-19Date of the 2024 Annual Meeting of Stockholders.

Keywords

Annual Meeting, Stockholder Proposals, Proxy Materials, Director Nomination, Corporate Governance, SEC Regulations

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.